The Medicines Control Council (MCC) is threatening to de-register Nevirapine unless further studies and appropriate documentation can show its efficacy in the prevention of mother to child transmisssion of HIV. Glenda Grey of the Peri-natal HIV Research Unit at Chris Hani Baragwanath Hospital argues that enough evidence has already been presented.

Days before South Africa signed its outstanding agreement with the Global Fund to release money to projects in KwaZulu-Natal, a senior advisor in the Fund, Vinand Nantulya, explained that further delays would jeopardise the funds.